云南白药集团股份有限公司2025年第二次临时股东大会决议公告

Meeting Overview - The second extraordinary general meeting of shareholders was held on November 10, 2025, with a total of 1,128 shareholders present, representing 1,112,305,695 shares, accounting for 62.34% of the total voting shares [5][6] - The meeting was conducted both in-person and via online voting, ensuring compliance with relevant laws and regulations [4][9] Resolutions Passed - The proposal to cancel the supervisory board and amend the company's articles of association was approved with 97.84% of the votes [9][10] - The proposal to amend the rules of procedure for shareholder meetings was approved with 96.42% of the votes [11][12] - The proposal to amend the rules of procedure for board meetings was also approved with 96.42% of the votes [13][14] Board Elections - The election of the 11th board of directors was conducted, with all candidates approved, including non-independent directors and independent directors [15][16][17][18][19][20][21][22][23][27][28][29][30][31][32][33] - Zhang Wenxue was elected as the chairman of the board, and Dong Ming was elected as the vice chairman [38][40] Legal Opinions - The legal opinions provided by Beijing Deheng (Kunming) Law Firm confirmed that the meeting's procedures and resolutions were in compliance with legal and regulatory requirements [35] Documentation - The resolutions and legal opinions from the meeting will be available for review, including signed confirmations from the attending directors [36]